Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

MLA

Di Pastena, Fiorella, et al. “Growth Differentiation Factor 15 (GDF15) Predicts Relapse Free and Overall Survival in Unresected Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy.” Radiation Oncology, vol. 19, no. 1, Nov. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13014-024-02546-y.

APA

Di Pastena, F., Pond, G., Tsakiridis, E. E., Gouveia, A., Ahmadi, E., Biziotis, O.-D., Ali, A., Swaminath, A., Okawara, G., Ellis, P. M., Abdulkarim, B., Ahmed, N., Robinson, A., Roa, W., Valdes, M., Kavsak, P., Wierzbicki, M., Wright, J., Steinberg, G., & Tsakiridis, T. (2024). Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy. Radiation Oncology, 19(1), 1–9. https://doi.org/10.1186/s13014-024-02546-y

Chicago

Di Pastena, Fiorella, Gregory Pond, Evangelia E. Tsakiridis, Andre Gouveia, Elham Ahmadi, Olga-Demetra Biziotis, Amr Ali, et al. 2024. “Growth Differentiation Factor 15 (GDF15) Predicts Relapse Free and Overall Survival in Unresected Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy.” Radiation Oncology 19 (1): 1–9. doi:10.1186/s13014-024-02546-y.